# Entos Pharmaceuticals receives $62M Canadian government grant for biomanufacturing facility

The Government of Canada announced a $62 million contribution to support Entos Pharmaceuticals' $198.5 million project to build a 103,000-square-foot biomanufacturing and R&D facility in Edmonton, Alberta. The facility will produce genetic medicines.

- Type: Investment
- Announced: 2025-03-11
- Where: Edmonton, Alberta, Canada
- Value: $138.0M (198.5M CAD)
- Jobs: 90
- Status: announced
- Products: genetic medicines, therapeutics, vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Entos Pharmaceuticals](https://endata.com/companies/83423.md)
- [Government of Canada](https://endata.com/companies/1351.md) (investor)

## Sources

- [newswire.ca](https://www.newswire.ca/fr/news-releases/canada-supports-biomanufacturing-capacity-to-advance-next-generation-medicines-870302113.html), 2025-03-11: "This contribution will help build a 103,000-square-foot facility consisting of a biomanufacturing facility and research and development (R&D) centre."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.